Multiplex Assay Kit for Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay)

P2CP; C-Propeptide Of Type II Procollagen; Procollagen II Carboxy Terminal Propeptide

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 87-101 93
EDTA plasma(n=5) 99-105 102
heparin plasma(n=5) 84-98 95

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 83-101% 79-90% 81-98% 99-105%
EDTA plasma(n=5) 83-96% 85-101% 80-91% 94-102%
heparin plasma(n=5) 96-105% 98-105% 88-98% 95-102%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:PIICP) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Experimental and Therapeutic Medicine Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A … 10.3892
Functional Foods in Health & Disease Evaluation of the effect of administering N-acetyl-glucosamine-containing green tea supplement on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: a randomized double-blind placebo-controlled clinical study 309
EXPERIMENTAL AND THERAPEUTIC MEDICINE Effect of N-acetylglucosamine administration on cartilage metabolism and safety in healthy subjects without symptoms of arthritis: A case report pubmed:28413518
Experimental and Therapeutic Medicine Evaluation of the effect of salmon nasal proteoglycan on biomarkers for cartilage metabolism in individuals with knee joint discomfort: A randomized double‑blind placebo‑controlled clinical study etm:14
Experimental and Therapeutic Medicine Evaluation of the efficacy of Ajuga decumbens extract supplement in individuals with knee discomfort associated with physical activity: A randomized, double‑blind, placebo‑controlled study 10.3892/etm.2017.5064
EXPERIMENTAL AND THERAPEUTIC MEDICINE Evaluation of the chondroprotective action of N‑acetylglucosamine in a rat experimental osteoarthritis pubmed:28912864
Functional Foods In Health And Disease Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals: a randomized double-blind placebo-controlled clinical study view/366
Spine No effects of hyperosmolar culture medium on tissue regeneration by human degenerated nucleus pulposus cells despite upregulation extracellular matrix genes fulltext:2018/03010
Advances in Clinical and Experimental Medicine Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with … 68362.pdf
Functional Food Research サケ鼻軟骨由来プロテオグリカン摂取による関節保護効果
Spine No Effects of Hyperosmolar Culture Medium on Tissue Regeneration by Human Degenerated Pubmed: 25856264
Applied Physiology Nutrition and Metabolism Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain; A randomized controlled trial Pubmed: 31990581
International Journal of Molecular Sciences Bone Morphogenetic Proteins for Nucleus Pulposus Regeneration Pubmed: 32295299
Biomolecules Concerted Actions by PIICP, CTXII, and TNF-¦Á in Patients with Juvenile Idiopathic Arthritis 33924892
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA964Hu01 Recombinant Procollagen II C-Terminal Propeptide (PIICP) Positive Control; Immunogen; SDS-PAGE; WB.
RPA964Hu02 Recombinant Procollagen II C-Terminal Propeptide (PIICP) Positive Control; Immunogen; SDS-PAGE; WB.
CPA964Hu21 OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP) Immunogen; SDS-PAGE; WB.
PAA964Hu08 Polyclonal Antibody to Procollagen II C-Terminal Propeptide (PIICP) WB; IHC; ICC; IP.
PAA964Hu01 Polyclonal Antibody to Procollagen II C-Terminal Propeptide (PIICP) WB; IHC; ICC; IP.
PAA964Hu02 Polyclonal Antibody to Procollagen II C-Terminal Propeptide (PIICP) WB; IHC; ICC; IP.
SEA964Hu ELISA Kit for Procollagen II C-Terminal Propeptide (PIICP) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA964Hu ELISA Kit for Procollagen II C-Terminal Propeptide (PIICP) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA964Hu Multiplex Assay Kit for Procollagen II C-Terminal Propeptide (PIICP) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA964Hu11 ELISA Kit DIY Materials for Procollagen II C-Terminal Propeptide (PIICP) Main materials for "Do It (ELISA Kit) Yourself".